Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <= 50 cp/mL

Madeddu, G; Rusconi, S; Cozzi-Lepri, A; Di Giambenedetto, S; Bonora, S; Carbone, A; De Luca, A; ... Antinori, A; + view all Madeddu, G; Rusconi, S; Cozzi-Lepri, A; Di Giambenedetto, S; Bonora, S; Carbone, A; De Luca, A; Gianotti, N; Di Biagio, A; Antinori, A; - view fewer (2017) Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA .

http://ift.tt/2FupH8M